Reduced biocide susceptibility in Candida albicans biofilms

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3411-3413

  Nett, Jeniel E ^a,b   Guite, Kristie M ^a   Ringeisen, Alex ^b   Holoyda, Kathleen A ^b   Andes, David R ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DODECYL SULFATE SODIUM; FLUCONAZOLE; HYDROGEN PEROXIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CONCENTRATION (PARAMETERS); NONHUMAN; PLANKTON; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; DISINFECTANTS; DRUG INTERACTIONS; DRUG RESISTANCE, FUNGAL; DRUG THERAPY, COMBINATION; ETHANOL; FLUCONAZOLE; HUMANS; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; SODIUM DODECYL SULFATE;

EID: 50949084578     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01656-07     Document Type: Article

References (46)

1. Ackoundou-N'guessan, C., A. E. Heng, S. Guenu, F. Charbonne, O. Traore, P. Deteix, and B. Souweine. 2006. Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis - first case report in dialysis setting. Nephrol. Dial. Transplant. 21:3339-3340.
2. Al-Fattani, M. A., and L. J. Douglas. 2004. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 48:3291-3297.
3. Andes, D., J. Nett, P. Oschel, R. Albrecht, K. Marchillo, and A. Pitula. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031.
4. Baillie, G. S., and L. J. Douglas. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother. 42:1900-1905.
5. Baillie, G. S., and L. J. Douglas. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46:397-403.
6. Cano-Parra, J., I. Bueno-Gimeno, B. Lainez, J. Cordoba, and R. Montes-Mico. 1999. Antibacterial and antifungal effects of soft contact lens disinfection solutions. Cont. Lens Anterior Eye 22:83-86.
7. Chambers, S. T., B. Peddie, and A. Pithie. 2006. Ethanol disinfection of plastic-adherent micro-organisms. J. Hosp. Infect. 63:193-196.
8. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
9. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
10. Clayton, Y. M., and G. Midgley. 1971. Estimation of dermatophytes (ringworm fungi) and Candida spores in the environment. J. Med. Microbiol. 4:P3-P4.
11. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
12. Cozad, A., and R. D. Jones. 2003. Disinfection and the prevention of infectious disease. Am. J. Infect. Control 31:243-254.
13. Donlan, R. M. 2001. Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 33:1387-1392.
14. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
15. Douglas, L. J. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 19:139-143.
16. Hawser, S. P., G. S. Baillie, and L. J. Douglas. 1998. Production of extracellular matrix by Candida albicans biofilms. J. Med. Microbiol. 47:253-256.
17. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
18. Hostetler, J. S., D. W. Denning, and D. A. Stevens. 1992. US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host. Chemotherapy 38(Suppl. 1):12-22.
19. Kojic, E. M., and R. O. Darouiche. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17:255-267.
20. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
21. Kuhn, D. M., and M. A. Ghannoum. 2004. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr. Opin. Investig. Drugs 5:186-197.
22. Kumamoto, C. A., and M. D. Vinces. 2005. Alternative Candida albicans lifestyles: growth on surfaces. Annu. Rev. Microbiol. 59:113-133.
23. Lamfon, H., Z. Al-Karaawi, M. McCullough, S. R. Porter, and J. Pratten. 2005. Composition of in vitro denture plaque biofilms and susceptibility to antifungals. FEMS Microbiol. Lett. 242:345-351.
24. Levin, D. E. 2005. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 69:262-291.
25. Mah, T. F., B. Pitts, B. Pellock, G. C. Walker, P. S. Stewart, and G. A. O'Toole. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310.
26. McDonnell, G. E. 2007. Antisepsis, disinfection, and sterilization: types, action, and resistance. ASM Press, Washington, DC.
27. Mukherjee, P. K., J. Chandra, D. M. Kuhn, and M. A. Ghannoum. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71:4333-4340.
28. Muzyka, B. C. 2005. Oral fungal infections. Dent. Clin. N. Am. 49:49-65, viii.
29. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing. Document M27-A2, 2nd ed. NCCLS, Wayne, PA.
30. Nett, J., L. Lincoln, K. Marchillo, R. Massey, K. Holoyda, B. Hoff, M. Vanhandel, and D. Andes. 2007. Putative role of β-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51:510-520.
31. Onland, W., C. E. Shin, S. Fustar, T. Rushing, and W. Y. Wong. 2006. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch. Pediatr. Adolesc. Med. 160:1049-1053.
32. O'Toole, G. A. 2003. To build a biofilm. J. Bacteriol. 185:2687-2689.
33. Pappas, P. G., J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, T. J. Walsh, and J. E. Edwards. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38:161-189.
34. Potera, C. 1999. Forging a link between biofilms and disease. Science 283:1837-1839.
35. Raad, I., H. Hanna, T. Dvorak, G. Chaiban, and R. Hachem. 2007. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob. Agents Chemother. 51:78- 83.
36. Ramage, G., S. Bachmann, T. F. Patterson, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49:973-980.
37. Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
38. Ramage, G., K. VandeWalle, S. P. Bachmann, B. L. Wickes, and J. L. Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.
39. Ramage, G., K. Vandewalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170.
40. Rosenthal, R. A., W. M. Bell, and R. Abshire. 1999. Disinfecting action of a new multi-purpose disinfection solution for contact lenses. Cont. Lens Anterior Eye 22:104-109.
41. Sopwith, W., T. Hart, and P. Garner. 2002. Preventing infection from reusable medical equipment: a systematic review. BMC Infect. Dis. 2:4.
42. Suci, P. A., and B. J. Tyler. 2002. Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm. Antimicrob. Agents Chemother. 46:3522-3531.
43. Szymanska, J. 2006. Antifungal efficacy of hydrogen peroxide in dental unit waterline disinfection. Ann. Agric. Environ. Med. 13:313-317.
44. Te Dorsthorst, D. T., P. E. Verweij, J. F. Meis, N. C. Punt, and J. W. Mouton. 2004. In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models. Antimicrob. Agents Chemother. 48:2007-2013.
45. Theraud, M., Y. Bedouin, C. Guiguen, and J. P. Gangneux. 2004. Efficacy of antiseptics and disinfectants on clinical and environmental yeast isolates in planktonic and biofilm conditions. J. Med. Microbiol. 53:1013-1018.
46. Webb, B. C., M. D. Willcox, C. J. Thomas, D. W. Harty, and K. W. Knox. 1995. The effect of sodium hypochlorite on potential pathogenic traits of Candida albicans and other Candida species. Oral Microbiol. Immunol. 10:334-341.